These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 7213473)
21. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organization World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684 [TBL] [Abstract][Full Text] [Related]
22. Rationale drug therapy: reasons for failure and suggestions for its implementation. Mathur GP; Kushwaha KP; Mathur S Indian Pediatr; 1993 Jun; 30(6):815-8. PubMed ID: 7726879 [No Abstract] [Full Text] [Related]
23. A new approach to quality training. Betts WA J Parenter Sci Technol; 1981; 35(5):248-50. PubMed ID: 7299602 [No Abstract] [Full Text] [Related]
24. [Standards of good production. Human and technical aspects]. Rocchi B Boll Chim Farm; 1975 Jan; 114(1):3-9. PubMed ID: 1203097 [No Abstract] [Full Text] [Related]
25. [Production and control in pharmaceutical industry. Quality control and guarantee of quality. Requirements of IKS-rules in the quality control]. Sahli M; Bircher M Pharm Acta Helv; 1973; 48(8):429-42. PubMed ID: 4766785 [No Abstract] [Full Text] [Related]
27. [Quality control in the process of drug production]. Lumini E Boll Chim Farm; 1978 Jan; 117(1):14-8. PubMed ID: 743348 [No Abstract] [Full Text] [Related]
28. [Quality of medicines in least developed countries]. Videau JY Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015 [TBL] [Abstract][Full Text] [Related]
29. [On the analytical results obtained with a controlled production according to the modern "standards of good manufacture"]. Mascellani G; Rocchi B Boll Chim Farm; 1971 Apr; 110(4):197-206. PubMed ID: 5111345 [No Abstract] [Full Text] [Related]
30. Process analytical technology and ASTM Committee E55. Watts DC; Afnan AM; Hussain AS Stand News; 2004 May; 32(5):25-7. PubMed ID: 15146856 [No Abstract] [Full Text] [Related]
31. Committee E55 on process analytical technology: a supplier's perspective. Clegg I Stand News; 2004 May; 32(5):28-31. PubMed ID: 15146857 [No Abstract] [Full Text] [Related]
32. [Introduction of a complex quality control system in a pharmaceutical factory]. Karkhut ID Farm Zh; 1979; (5):67-70. PubMed ID: 499459 [No Abstract] [Full Text] [Related]
33. Development of specifications for biotechnology products--perspective from Europe. Trouvin JH Dev Biol Stand; 1997; 91():25-30. PubMed ID: 9413679 [No Abstract] [Full Text] [Related]
34. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474 [TBL] [Abstract][Full Text] [Related]
35. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
36. [Problems with standardization and quality control in Argentina with respect to teaching and testing]. Pinto FE Acta Odontol Venez; 1973 Apr; 11(1):58-67. PubMed ID: 4143805 [No Abstract] [Full Text] [Related]
38. PDA response. FDA advance notice of proposed rulemaking on electronic identification/signatures. Parenteral Drug Association. J Parenter Sci Technol; 1993; 47(1):4-8. PubMed ID: 8445499 [No Abstract] [Full Text] [Related]
39. Assuring the quality of the nation's drugs. Interview by William E. Small. Michels D Am Pharm; 1980 Apr; NS20(4):40-2. PubMed ID: 7386377 [No Abstract] [Full Text] [Related]
40. Production of quality drug products demands never ending attention. Timberlake CV Mich Med; 1974 Jan; 73(2):38-9 passim. PubMed ID: 4813106 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]